These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
852 related items for PubMed ID: 10409724
1. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells. Kim H, Baumann H. Mol Cell Biol; 1999 Aug; 19(8):5326-38. PubMed ID: 10409724 [Abstract] [Full Text] [Related]
2. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression. Schaper F, Gendo C, Eck M, Schmitz J, Grimm C, Anhuf D, Kerr IM, Heinrich PC. Biochem J; 1998 Nov 01; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795 [Abstract] [Full Text] [Related]
3. Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells. Kim H, Hawley TS, Hawley RG, Baumann H. Mol Cell Biol; 1998 Mar 01; 18(3):1525-33. PubMed ID: 9488469 [Abstract] [Full Text] [Related]
4. TNF-alpha induces tyrosine phosphorylation and recruitment of the Src homology protein-tyrosine phosphatase 2 to the gp130 signal-transducing subunit of the IL-6 receptor complex. Bode JG, Schweigart J, Kehrmann J, Ehlting C, Schaper F, Heinrich PC, Häussinger D. J Immunol; 2003 Jul 01; 171(1):257-66. PubMed ID: 12817006 [Abstract] [Full Text] [Related]
5. Modulation of hepatic acute phase gene expression by epidermal growth factor and Src protein tyrosine kinases in murine and human hepatic cells. Wang Y, Ripperger J, Fey GH, Samols D, Kordula T, Wetzler M, Van Etten RA, Baumann H. Hepatology; 1999 Sep 01; 30(3):682-97. PubMed ID: 10462375 [Abstract] [Full Text] [Related]
6. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1. Kortylewski M, Heinrich PC, Mackiewicz A, Schniertshauer U, Klingmüller U, Nakajima K, Hirano T, Horn F, Behrmann I. Oncogene; 1999 Jun 24; 18(25):3742-53. PubMed ID: 10391682 [Abstract] [Full Text] [Related]
8. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation. Anhuf D, Weissenbach M, Schmitz J, Sobota R, Hermanns HM, Radtke S, Linnemann S, Behrmann I, Heinrich PC, Schaper F. J Immunol; 2000 Sep 01; 165(5):2535-43. PubMed ID: 10946280 [Abstract] [Full Text] [Related]
9. Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase. Giordano V, De Falco G, Chiari R, Quinto I, Pelicci PG, Bartholomew L, Delmastro P, Gadina M, Scala G. J Immunol; 1997 May 01; 158(9):4097-103. PubMed ID: 9126968 [Abstract] [Full Text] [Related]
10. Protein tyrosine phosphatase epsilonC selectively inhibits interleukin-6- and interleukin- 10-induced JAK-STAT signaling. Tanuma N, Shima H, Nakamura K, Kikuchi K. Blood; 2001 Nov 15; 98(10):3030-4. PubMed ID: 11698287 [Abstract] [Full Text] [Related]
11. Gab1 acts as an adapter molecule linking the cytokine receptor gp130 to ERK mitogen-activated protein kinase. Takahashi-Tezuka M, Yoshida Y, Fukada T, Ohtani T, Yamanaka Y, Nishida K, Nakajima K, Hibi M, Hirano T. Mol Cell Biol; 1998 Jul 15; 18(7):4109-17. PubMed ID: 9632795 [Abstract] [Full Text] [Related]
13. The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells. Frearson JA, Alexander DR. J Exp Med; 1998 May 04; 187(9):1417-26. PubMed ID: 9565634 [Abstract] [Full Text] [Related]
14. Interaction of the tyrosine phosphatase SHP-2 with Gab2 regulates Rho-dependent activation of the c-fos serum response element by interleukin-2. Arnaud M, Mzali R, Gesbert F, Crouin C, Guenzi C, Vermot-Desroches C, Wijdenes J, Courtois G, Bernard O, Bertoglio J. Biochem J; 2004 Sep 01; 382(Pt 2):545-56. PubMed ID: 15170389 [Abstract] [Full Text] [Related]
15. The STAT3-independent signaling pathway by glycoprotein 130 in hepatic cells. Lai CF, Ripperger J, Wang Y, Kim H, Hawley RB, Baumann H. J Biol Chem; 1999 Mar 19; 274(12):7793-802. PubMed ID: 10075671 [Abstract] [Full Text] [Related]
16. Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes. Kunisada K, Hirota H, Fujio Y, Matsui H, Tani Y, Yamauchi-Takihara K, Kishimoto T. Circulation; 1996 Nov 15; 94(10):2626-32. PubMed ID: 8921810 [Abstract] [Full Text] [Related]
17. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor. Wang Y, Robledo O, Kinzie E, Blanchard F, Richards C, Miyajima A, Baumann H. J Biol Chem; 2000 Aug 18; 275(33):25273-85. PubMed ID: 10854424 [Abstract] [Full Text] [Related]
18. Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia. Kim HY, Park EJ, Joe EH, Jou I. J Immunol; 2003 Dec 01; 171(11):6072-9. PubMed ID: 14634121 [Abstract] [Full Text] [Related]